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Abstract 
 
Objectives: Patients with dementia in the acute setting are generally considered to impose higher 
costs on the health system compared to those without the disease largely due to longer length of stay 
(LOS). Many studies exploring the economic impact of the disease extrapolate estimates based on the 
costs of patients diagnosed using routinely collected hospital discharge data only. However, much 
dementia is undiagnosed and therefore in limiting the analysis to this cohort, we believe that LOS and 
the associated costs of dementia may be overestimated. We examined LOS and associated costs in a 
cohort of patients specifically screened for dementia in the hospital setting. 
 
Methods: Using primary data collected from a prospective observational study of patients aged >/= 
70yrs, we conducted a comparative analysis of LOS and associated hospital costs for patients with and 
without a diagnosis of dementia.   
 
Results: There was no significant difference in overall length of stay and total costs between those 
with (µ = 9.9 days, µ = €8,246) and without (µ = 8.25 days, µ = €6,855) dementia. Categorical data 
analysis of LOS and costs between the two groups provided mixed results. 
 
Conclusions: The results challenge the basis for estimating the costs of dementia in the acute setting 
using LOS data from only those patients with a formal dementia diagnosis identified by routinely 
collected hospital discharge data. Accurate disease prevalence data, encompassing all stages of 
disease severity, is required to enable an estimation of the true costs of dementia in the acute setting 
based on LOS.  
 
Keywords  
dementia, screening, acute setting, length of stay, costs, older people 
 
Key Points 
• Studies that explore the economic impact of dementia by extrapolating estimates based on the 
length of stay and costs of patients diagnosed using routinely collected hospital discharge data 
only may be overestimated. 
• When patients were screened for dementia on admission to the acute setting, we found no 
significant difference in overall length of stay and total costs between those with and without the 
disease. 
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• Accurate disease prevalence data, encompassing all stages of disease severity, is required to 
enable an estimation of the true costs of dementia in the acute setting based on length of stay. 
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Main Text 
 
Introduction 
Dementia is a serious chronic condition, typically affecting older people, and imposes a substantial 
economic burden on the health system and society.1 The most recent figures estimate the global cost 
of dementia at US$818 billion, representing over 1% of the world’s GDP.2 Population ageing, the 
dominant demographic trend of this century, is cited as the main driver of this global epidemic,3 
anticipated to become a trillion dollar disease by 2018.2 It is of note that dementia differs from other 
conditions by the way in which its costs are distributed across a variety of public and private 
resources.4 The cost of dementia in Western Europe is reported at €263 billion, of which 19% is 
attributable to direct medical costs, with the remaining costs falling on the social care (43%) and 
informal care (38%) sectors.3   
The most recent estimates for Ireland reveal that in 2016 dementia affected 55,000 people (1.16% of 
the overall population), of which just under 47,600 were adults aged 70yrs+, and it is projected that 
the number of people affected by the disease will triple by 2041.5 It is widely accepted that much 
dementia remains undiagnosed, with between 50-80% of people affected having no formal diagnosis 
of their condition.6-11  Furthermore, it has been identified that dementia is underestimated in hospital 
registries, 12-21 due to limitations with coding systems, insufficient diagnoses and the failure to 
document and record dementia as a diagnosis even when the diagnosis has been established.12,13,20 
Reports of the prevalence rate of dementia in the acute-care setting range from 3.9% to 22%, 
depending on the hospital and age cohort under consideration.7,12,22 A recent Irish multi-hospital 
observational study identified a dementia prevalence of 25% amongst older hospitalised patients of 
whom just over 35% had a previously known diagnosis (listed in GP letter, medical notes or report of 
a family member).  Of those with a known diagnosis of dementia, only 20% of cases had been captured 
by the hospital in-patient enquiry (HIPE) registry.13,15 
Patients with dementia in the acute setting are generally considered to impose higher costs on the 
health system.  This is reflected in longer length of stay (LOS) compared to those the same age without 
the disease,7,12,16,17,20,22-33 increased risk of in-hospital complications,21,34 safety and behavioural issues 
requiring 1:1 care, and a higher risk of readmission.21 However, many of these studies that explore the 
economic impact of the disease extrapolate estimates based on the costs of formally diagnosed 
patients only.23,33,35-37  An Irish study examining the additional hospital days due to dementia estimated 
an associated annual cost of >€199 million to the Irish health system.35 These marginal costs were 
determined by assessing the additional LOS for those with a known diagnosis of dementia captured 
by the HIPE system and multiplying this excess LOS by the estimated dementia hospital admissions 
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based on European age specific prevalence rates.35 However, in limiting the analysis of a dementia 
cohort to those with a formal diagnosis only, and by extension the most severely impaired patients, 
we believe that LOS in hospital and the associated costs of dementia may be overestimated. 
In light of the hypothesis that dementia imposes higher direct medical costs on the health system 
largely due to longer LOS in hospital, but with supporting evidence that much dementia is 
undiagnosed, our study examines LOS and associated costs in a cohort that was specifically screened 
for dementia in the hospital setting. 
Using primary data collected by Timmons et al15 on the true prevalence of dementia in the hospital 
setting  we can accurately compare LOS and associated costs for those with and without dementia. 
With an ageing demographic profile and the consequent economic pressures on the health system, 
robust data on the prevalence and the economic impact of dementia on the acute setting is required. 
This information is fundamental to inform policy makers on appropriate resource allocation in 
planning for a sustainable health-system and highlighting priorities for future research. 
 
Methods 
We used primary data from a non-consecutive, prospective cohort study of patients aged >/= 70yrs, 
including elective (non-day case) and unplanned admissions to any speciality across six acute hospitals 
in Cork County between May 2012 and February 2013 (14 collection days per hospital: pre-planned 
and staggered over 6 weeks; all days of week evenly represented; all patients admitted in the 24-hour 
period included).15 In this study, patients consenting to inclusion and not critically ill had been assessed 
within 48 hours of admission (90% of all admissions included, n=606). Researcher-defined dementia 
status (possible in 598/606) was ascertained by initial MMSE38 screening (score ≥27/30 coded as non-
dementia; expected 2% under-diagnosis rate)22 and then expert review of detailed researcher-
collected patient data: standardised collateral history (IQCODE informant tool),39 delirium status (DRS-
R98),40 depression screen (GDS-5),41 hearing and vision screens, education history, presenting illness 
details, past history of cognitive or mental health disorder.  In this highly-characterised cohort, we 
conducted a comparative analysis of LOS and the associated hospital costs for patients with and 
without a diagnosis of dementia in the 594 patients with available LOS data. Of note, this analysis does 
not include the costs of delirium, whether in isolation, or superimposed on dementia. 
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Hospital resource utilisation 
 
The dates of admission to and discharge from hospital were captured at the individual patient level. 
This enabled the calculation of LOS, recorded as the number of days spent in hospital.  To ensure 
accuracy with this data, LOS was also crosschecked with the longitudinal data captured for each 
patient. In certain cases, one-to-one monitoring was required to ensure patient safety and well-being 
in the hospital setting. The allocation of a special carer (SC) to perform this monitoring and the number 
of days that each patient spent receiving one-to-one care from a SC were recorded.   
 
 
Calculation of healthcare costs 
 
Costs of healthcare resource utilisation were collected from the Irish health payer’s perspective, the 
Health Service Executive (HSE), and are presented in 2013 Euro.  Costs included the hospital cost of an 
inpatient bed and the cost of a SC. Irish hospitals don’t have a standard methodology for recording 
costs at the ward or hospital level. To overcome this irregularity, the study used the aggregate in-
patient bed per diem cost for 2012 and 2013 as appropriate, obtained from correspondence with the 
Healthcare Pricing Office of the HSE.  2012 in-patient bed per diem costs were adjusted to 2013 Euro 
using the annual consumer price index rates as published by the Central Statistics Office in Ireland.42 
Due to the study’s perspective, the public in-patient per diem costs were also applied to the private 
hospital included in the analysis.  
To estimate the cost of a SC we assumed that for the case of male patients, SCs were male porters and 
for female patients, SCs were female healthcare assistants. This decision was made in agreement with 
the consulting geriatrician (ST). Salaries were determined from the New Entrant (mid-point) Health 
Sector Salary Scales effective from 1 July 2013.43 As per guidelines issued by the  Irish Health 
Information and Quality Authority,44 salaries were adjusted for employer’s social insurance, imputed 
pension costs and overheads, from which a daily cost for a SC was estimated.  
 
Statistical Analysis 
 
Data were entered into FileMaker Pro 11 database and transferred to SPSS version 22 [IBM Co., 
Chicago, IL, USA] for analysis. Descriptive statistics of patient characteristics are presented as 
frequencies and percentages, and continuous variables are presented as mean +/- SD.  Due to 
positively skewed LOS and hospital cost data, we applied non-parametric techniques to analyse the 
data.  A series of Mann Whitney-U tests were performed to compare differences in LOS and costs 
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between the two patient groups, that is, those with and without hospital diagnosed dementia.  A Chi-
square test for independence was conducted to indicate the association between dementia status and 
the presence of a SC. The daily cost of a SC was subject to sensitivity analysis where the cost was varied 
by + and – 50%. Statistical significance was determined using P < 0.05. 
 
Results  
Overview of all patients enrolled in the study 
 
Of the 594 patients enrolled in the study, 304 (51.2%) were female and 290 (48.8%) were male, ranging 
in age from 70 to 99 years (µ = 79.7 years, SD = 6.6). The majority of patients were based in a public 
hospital (81.1%) and admitted via the emergency department (70.9%). Medical admissions (66.2%) 
were most prevalent followed by surgical (21.4%), and geriatric and orthopaedic combined (12.3%). 
The most common presenting diagnosis was surgery/procedure (19.7%), followed by cardiac 
conditions (16.8%), pneumonia (10.9%), gastrointestinal issues (9.3%) and respiratory illnesses (7.2%).  In 
terms of the patients living arrangements prior to admittance, 62.3% patients were living at home 
with their partner or other family members, almost 30% were living on their own, and the remaining 
patients were resident in a nursing home (5.9%) or came from sheltered accommodation (3%).   
 
Dementia 
 
Dementia was present in almost a quarter of patients (24.9%).  Of these patients, 64% had no previous 
diagnosis of dementia prior to presenting to hospital.  The prevailing principal diagnosis within the 
cohort with dementia was pneumonia (18.2%), followed by cardiac conditions (15.5%); 
gastrointestinal issues (7.4%) and urinary tract infections (5.4%).  Timmons et al15 provides a full 
breakdown of the demographic and clinical statistics of patients with and without dementia.   
 
Length of stay  
 
Mean LOS in hospital for the study cohort was 8.66 days (min. = 1, max. = 219, SD = 12.88). The average 
LOS in the dementia group was 9.9 days (SD = 11.20), (‘previously diagnosed dementia’ = 10.19 days 
and ‘research-categorised as dementia; not previously diagnosed = 9.74 days). This compared with 
8.25 days (SD = 13.38) for those without dementia (Table 1). The difference between the two cohorts 
was non-significant (p= 0.108).  
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The difference in LOS between the two groups was interrogated using the following categories; 
gender; age group; admission type; hospital type and location; speciality of the admitting team; 
patient living arrangements prior to admittance to hospital; patient discharge arrangements and 
primary diagnosis at admission (Table 1). Results varied, but mean LOS was shorter for those with a 
dementia diagnosis in the following instances on admission: to a rural hospital, geriatric & orthopaedic 
admitting team, coming from a sheltered home and coming from a nursing home. At admission, 
patients were diagnosed with one of ten conditions. In the case of four of these conditions; 
respiratory, infection, stroke and surgery/procedure, mean LOS was shorter for those with a dementia 
diagnosis.  Based on destination at discharge alone, mean LOS was shorter for the dementia cohort 
compared to the cohort without dementia when discharged to nursing homes for long term care and 
to short term care facilities (noting that 60% of those with dementia discharged to a nursing home 
already resided there pre-admission, compared to 50% of those without dementia). When patients 
died in hospital, the number of days to death was shorter in the cohort with dementia.  Discharge to 
home was the only instance where mean LOS was longer in the group with dementia.  
Significant differences in LOS were observed between the two groups in two categories; (i) the 
patient’s living arrangements prior to admission to hospital and (ii) the primary diagnosis at admission. 
A longer LOS was observed for the dementia cohort (µ =11.61 days) compared to the non-dementia 
group (µ = 7.55 days) in the case where they were living with a partner or other family member prior 
to admission.  Conversely, a shorter LOS was identified in the dementia group (µ = 2.4 days) compared 
to the non-dementia group (µ = 5.87 days) where the admitting diagnosis was for a surgical procedure.  
 
INSERT TABLE 1 HERE 
 
Special Carers (SC) 
 
36 patients in total (6.1% of the study cohort) required one to one care during their hospital stay, 
10.8% (n=16) of those with a dementia diagnosis and 4.5% (n=20) of those without a dementia 
diagnosis. A Chi-square test for independence indicated a significant association between the 
presence of dementia and the requirement for a SC; 2 (1, n=594] = 6.7, p = 0.009).  
For those patients allocated a SC, the number of days with the carer ranged from 1 to 24 with a mean 
of 4.47 days. The mean number of days with the carer was lower in the group diagnosed with dementia 
(µ = 3.38 days) compared to the group without dementia (µ = 5.35 days). Additionally, for those 
allocated a SC, the mean LOS in hospital was non-significantly lower in patients with dementia than 
without (µ = 16.31 days dementia v 19.70 days no dementia).  
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Costs 
 
Inpatient bed 
The cost of an overnight inpatient bed, as advised by the Healthcare Pricing Office of the HSE, is €829 
for 2012 (adjusted to 2013 prices) and €815 for 2013. Using length of stay data, the mean total cost 
of an inpatient bed for the study cohort was €7,158 (SD = €10,574). The mean cost for patients with 
dementia was €8,186 (SD = €9,262), higher than those without dementia (µ = €6,816, SD = €10,963). 
However, the difference of €1,370 was not statistically significant.  
 
SC 
The daily cost of a SC was calculated as €161 for a male SC and €169 for a female SC. The average total 
cost of a special carer was €730 (min. = €161, max. = €3,864, SD = €869), but lower for patients with 
dementia (µ = €555, SD= €522), compared to those without dementia (µ = €871, SD = €1,063). Again, 
the difference in mean cost was not statistically significant.  
 
Total cost 
Combining the cost of an inpatient bed and the cost of a special carer, the mean total cost per patient 
in the study cohort was €7,202 (SD = €10,654).  A comparison of total costs between the two patient 
cohorts revealed higher costs for those with dementia (µ = €8,246 dementia v €6,855 no dementia) (Table 2), 
(µ = €8,512 previously diagnosed dementia v µ = €8,098 research-categorised as dementia; not previously diagnosed). However, this 
difference was non-significant. The group with dementia reported a median total cost of = €4,560 
(n=148) compared with €4,145 (n= 446) in the group without dementia, MWU = 30103.5, z = -1.61, p 
= 0.108. Varying the daily cost of special carers by + and - 50% in the sensitivity analysis did not alter 
the results.  
 
INSERT TABLE 2 HERE 
 
Discussion 
Current estimates of the cost of dementia in the hospital setting typically use the difference in LOS 
between a dementia and non-dementia patient cohort as a proxy for the marginal cost of the disease 
along with reported prevalence rates to determine the total cost of the disease.21,31,33 This limits 
analyses to patients with a formal diagnosis of the disease.  Though these studies do highlight the fact 
that their analysis is limited to formally diagnosed patients, they mainly postulate that disease costs 
are underestimated due to the under-diagnosis of the disease.17,21 However, this study highlights the 
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potential nuances present in this approach.  In terms of identifying the marginal cost of the disease, 
we propose that using LOS data for the dementia patient group from hospital registries, specifically 
patients with a formal diagnosis, limits the analysis to a more severely impaired population and 
therefore may not lead to an accurate measurement of costs. To our knowledge, this is the first study 
that compares direct hospital resource utilisation and costs between patients with and without 
dementia where the disease is specifically diagnosed in the hospital setting. Our study finds no 
significant difference in terms of LOS and associated costs between those with and without dementia. 
The findings are aligned with a study performed within the German Study on Ageing, Cognition and 
Dementia in Primary Care Patients, which considered the net costs of dementia by disease stage. 
Similarly no significant differences in mean annual costs for in-patient treatment was found between 
dementia and non-dementia patients.45 While subjects for this German study were recruited through 
GPs, dementia was also specifically diagnosed as part of the study by an experienced geriatrician or 
geriatric psychiatrist.46 Our study findings highlight the fact that continued use of hospital 
discharge/registry based data for sourcing dementia prevalence rates and associated LOS in order to 
calculate dementia care costs in the hospital setting, may provide misleading estimates and should be 
treated with caution.  
 
Limitations 
 
Given that previous studies largely determine the direct medical costs of dementia primarily based on 
hospital LOS data, we confined our analysis of hospital costs to the cost of an inpatient bed based on 
LOS and the cost of a special carer based on length of time with the carer. We acknowledge that this 
doesn’t allow us to capture the full cost of inpatient hospital care. However, we believe that with 
accurate prevalence data, an analysis of costs based on LOS provides a valid starting point for 
comparing the true costs of inpatient care for those with and without dementia.   
While the cost of SCs has been estimated based on the salaries of full time permanent staff, we are 
aware that porters and health care assistants in Ireland are frequently hired through agencies and so 
in reality would be more expensive. Whilst it is not feasible to cost for SCs hired through agencies for 
this study, we have calculated the daily cost based solely on the number of working days in the year, 
that is, excluding weekend days, public holidays and an annual leave allowance of 25 days. 
Furthermore, the cost of special carers has been subject to sensitivity analysis where the cost was 
stressed by + and - 50%, with no impact on the results. 
 
Conclusion 
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Dementia has been described as the greatest global challenge for health and social care this century,47 
with a risk that healthcare systems could be overwhelmed by the costs of providing care for those 
with the disease into the future.48 At a time when many healthcare agencies are competing for limited 
resources, accurate and reliable estimates of costs are increasingly required to ensure that decisions 
on the implementation of public health policy and the allocation of healthcare funding will have the 
desired effect. The results of this work challenge the basis for estimating the costs of dementia in the 
acute care setting based solely on the LOS of those with a formal diagnosis of the disease and who 
have been captured within routine hospital discharge data. The study highlights the importance of 
establishing accurate disease prevalence data in the first instance, encompassing all stages of disease 
severity, to then enable an estimation of the true costs of dementia in the acute care setting based on 
patients’ LOS in hospital.  
 
Funding 
This work was supported by the Health Research Board grant number HRA HSR/2011/4. The 
investigators were solely responsible for the design, planning, conducting, interpretation and 
publication of this study and the funding source did not participate in such.  
 
 
 
 
 
 
 
12 
 
REFERENCES 
 
1. World Health Organization. First WHO ministerial conference on global action against 
dementia: meeting report, WHO Headquarters, Geneva, Switzerland, 16-17 March 2015. 2015. 
http://www.who.int/mediacentre/events/meetings/2015/global-action-against-dementia/en/ 
Accessed February 1, 2018. 
2. Prince M, Wimo A, Guerchet M, Ali G, Wu Y, Prina M. World Alzheimer Report 2015. The 
global impact of dementia. An analysis of prevalence, incidence, cost and trends; Alzheimer’s 
Disease International: London. London: Alzheimer’s Disease International, 2015. 
3. Prince M, Guerchet M, Prina M. The epidemiology and impact of dementia: current state 
and future trends. Geneva: World Health Organization, 2015. 
4. Cahill S, O'Shea E, Pierce M. Creating Excellence in Dementia Care. A Research Review for 
Ireland's National Dementia Strategy. Dublin: DSIDC’s Living with Dementia Research Programme, 
2012. 
5. O'Shea E, Cahill S, Pierce M, et al. Developing and Implementing Dementia Policy in Ireland: 
NUI Galway and Centre for Economic and Social Research on Dementia, 2017. 
6. Russ TC, Shenkin SD, Reynish E, Ryan T, Anderson D, MacLullich AM. Dementia in acute 
hospital inpatients: the role of the geriatrician. Age and Ageing 2012; 41(3): 282-4. 
7. Sampson EL, Blanchard MR, Jones L, Tookman A, King M. Dementia in the acute hospital: 
prospective cohort study of prevalence and mortality. The British Journal of Psychiatry 2009; 195(1): 
61-6. 
8. Savva GM, Arthur A. Who has undiagnosed dementia? A cross-sectional analysis of 
participants of the Aging, Demographics and Memory Study. Age and Ageing 2015; 44(4): 642-7. 
9. Alzheimer's Society, Alzheimer's Scotland, Tesco. Mapping the Dementia Gap. London: 
Alzheimer's Society, 2011. 
10. Michalowsky B, Eichler T, Thyrian JR, et al. Healthcare resource utilization and cost in 
dementia: are there differences between patients screened positive for dementia with and those 
without a formal diagnosis of dementia in primary care in Germany? International psychogeriatrics 
2016; 28(3): 359-69. 
11. Goldberg SE, Whittamore KH, Harwood RH, et al. The prevalence of mental health problems 
among older adults admitted as an emergency to a general hospital. Age and Ageing 2011; 41(1): 80-
6. 
12. Guijarro R, San Román CM, Gomez-Huelgas R, et al. Impact of dementia on hospitalization. 
Neuroepidemiology 2010; 35(2): 101-8. 
13. Brady NM, Manning E, O'Shea E, O'Regan NA, Meagher D, Timmons S. Hospital discharge 
data‐sets grossly under‐represent dementia‐related activity in acute hospitals: a cohort study in five 
Irish acute hospitals. International Journal of Geriatric Psychiatry 2016; 31(12): 1371-2. 
14. Gordon A, Hu H, Byrne A, Stott DJ. Dementia screening in acute medical and geriatric 
hospital admissions. The Psychiatrist 2009; 33(2): 52-4. 
15. Timmons S, Manning E, Barrett A, et al. Dementia in older people admitted to hospital: a 
regional multi-hospital observational study of prevalence, associations and case recognition. Age and 
Ageing 2015; 44(6): 993-9. 
16. CHKS. An economic analysis of the excess costs for acute care for patients with dementia. 
UK: CHKS, 2013. 
17. Torian L, Davidson E, Fulop G, Sell L, Fillit H. The effect of dementia on acute care in a 
geriatric medical unit. International Psychogeriatrics 1992; 4(02): 231-9. 
18. Joray S, Wietlisbach V, Büla CJ. Cognitive impairment in elderly medical inpatients: detection 
and associated six-month outcomes. The American Journal of Geriatric Psychiatry 2004; 12(6): 639. 
19. Mukadam N, Sampson EL. A systematic review of the prevalence, associations and outcomes 
of dementia in older general hospital inpatients. International Psychogeriatrics 2011; 23(03): 344-55. 
13 
 
20. Bynum JP, Rabins PV, Weller W, Niefeld M, Anderson GF, Wu AW. The relationship between 
a dementia diagnosis, chronic illness, Medicare expenditures, and hospital use. Journal of the 
American Geriatrics Society 2004; 52(2): 187-94. 
21. Tropea J, LoGiudice D, Liew D, Gorelik A, Brand C. Poorer outcomes and greater healthcare 
costs for hospitalised older people with dementia and delirium: a retrospective cohort study. 
International Journal of Geriatric Psychiatry 2017; 32(5): 539-47. 
22. Travers C, Byrne G, Pachana N, Klein K, Gray L. Prospective observational study of dementia 
and delirium in the acute hospital setting. Internal Medicine Journal 2013; 43(3): 262-9. 
23. Connolly S, Gillespie P, O’Shea E, Cahill S, Pierce M. Estimating the economic and social costs 
of dementia in Ireland. Dementia 2014; 13(1): 5-22. 
24. Kiejna A, Frydecka D, Adamowski T, et al. Epidemiological studies of cognitive impairment 
and dementia across Eastern and Middle European countries (epidemiology of dementia in Eastern 
and Middle European Countries). International Journal of Geriatric Psychiatry 2011; 26(2): 111-7. 
25. Misiak B, Cialkowska‐Kuzminska M, Frydecka D, Chladzinska‐Kiejna S, Kiejna A. European 
studies on the prevalence of dementia in the elderly: time for a step towards a methodological 
consensus. International Journal of Geriatric Psychiatry 2013; 28(12): 1211-21. 
26. Briggs R, Coary R, Collins R, Coughlan T, O’Neill D, Kennelly S. Acute hospital care: how much 
activity is attributable to caring for patients with dementia? QJM: An International Journal of 
Medicine 2015; 109(1): 41-4. 
27. King B, Jones C, Brand C. Relationship between dementia and length of stay of general 
medical patients admitted to acute care. Australasian Journal on Ageing 2006; 25(1): 20-3. 
28. Zekry D, Herrmann FR, Grandjean R, et al. Does dementia predict adverse hospitalization 
outcomes? A prospective study in aged inpatients. International Journal of Geriatric Psychiatry 2009; 
24(3): 283-91. 
29. Lyketsos CG, Sheppard J-ME, Rabins PV. Dementia in elderly persons in a general hospital. 
American Journal of Psychiatry 2000; 157(5): 704-7. 
30. Wancata J, Windhaber J, Krautgartner M, Alexandrowicz R. The consequences of non-
cognitive symptoms of dementia in medical hospital departments. The International Journal of 
Psychiatry in Medicine 2003; 33(3): 257-71. 
31. Zhu CW, Cosentino S, Ornstein K, Gu Y, Andrews H, Stern Y. Use and cost of hospitalization in 
dementia: longitudinal results from a community‐based study. International Journal of Geriatric 
Psychiatry 2015; 30(8): 833-41. 
32. Annear MJ, Tierney LT, Vickers JC, Palmer AJ. Counting the cost of dementia‐related hospital 
admissions: A regional investigation. Australasian Journal on Ageing 2016; 35(3). 
33. Motzek T, Junge M, Marquardt G. Impact of dementia on length of stay and costs in acute 
care hospitals. Zeitschrift fur Gerontologie und Geriatrie 2017; 50(1): 59-66. 
34. Daiello LA, Gardner R, Epstein-Lubow G, Butterfield K, Gravenstein S. Association of 
dementia with early rehospitalization among Medicare beneficiaries. Archives of gerontology and 
geriatrics 2014; 59(1): 162-8. 
35. Connolly S, O’Shea E. The impact of dementia on length of stay in acute hospitals in Ireland. 
Dementia 2015; 14(5): 650-8. 
36. Prince M, Knapp M, Guerchet M, et al. Dementia UK: Second edition - Overview. London: 
Alzheimer’s Society, 2014. 
37. Schwarzkopf L, Menn P, Kunz S, et al. Costs of care for dementia patients in community 
setting: an analysis for mild and moderate disease stage. Value in Health 2011; 14(6): 827-35. 
38. Molloy DW, Standish TI. A guide to the standardized Mini-Mental State Examination. 
International Psychogeriatrics 1997; 9(1): 87-94. 
39. Jorm A, Korten A. Assessment of cognitive decline in the elderly by informant interview. The 
British Journal of Psychiatry 1988; 152(2): 209-13. 
14 
 
40. Trzepacz PT, Mittal D, Torres R, Kanary K, Norton J, Jimerson N. Validation of the Delirium 
Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for 
delirium. The Journal of neuropsychiatry and clinical neurosciences 2001; 13(2): 229-42. 
41. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression 
screening scale: a preliminary report. Journal of psychiatric research 1982; 17(1): 37-49. 
42. Central Statistics Office. Statistical Product - Consumer Prices Annual Series 2017. 
http://www.cso.ie/px/pxeirestat/Database/eirestat/Consumer%20Prices%20Annual%20Series/Cons
umer%20Prices%20Annual%20Series_statbank.asp?sp=Consumer%20Prices%20Annual%20Series 
Accessed February 1, 2018. 
43. Health Service Executive. Health Sector. Consolidated Salary Scales in accordance with 
Financial Emergency Measures in the Public Interest Act 2013 (No. 18 of 2013). 2013. 
https://www.hse.ie/eng/staff/benefitsservices/pay/July%202013.pdf Accessed February 1, 2018. 
44. HIQA. Guidelines for the Economic Evaluation of Health Technologies in Ireland. Dublin: 
Health Information and Quality Authority, 2014. 
45. Leicht H, Heinrich S, Heider D, et al. Net costs of dementia by disease stage. Acta Psychiatrica 
Scandinavica 2011; 124(5): 384-95. 
46. Zaudig M, Mittelhammer J, Hiller W, et al. SIDAM–A structured interview for the diagnosis of 
dementia of the Alzheimer type, multi-infarct dementia and dementias of other aetiology according 
to ICD-10 and DSM-III-R. Psychological medicine 1991; 21(1): 225-36. 
47. Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. 
Lancet 2017; 390(10113): 2673-734. 
48. Frankish H, Horton R. Prevention and management of dementia: a priority for public health. 
Lancet 2017; 390(10113): 2614-5. 
 
 
 
 
 
 
 
15 
 
Table 1  Length of stay statistics of patients with and without dementia 
Factor Dementia              
Mean (SD)† 
No Dementia                
Mean (SD)† 
Dementia    
Median (IQR)‡ 
No Dementia 
Median (IQR)‡ 
Test P-value 
Overall 9.90 (11.199) 8.25 (13.379) 5.50 (9) 5.00 (6) MWU = 30110.0 0.108 
Gender       
  Male 9.31 (11.819) 7.55 (8.656) 5.00 (6) 5.00 (6) MWU = 6974.0 0.872 
  Female 10.33 (10.780) 8.98 (16.960) 5.00 (6) 5.00 (6) MWU = 8117.5 0.608 
Age Group       
  70-79yrs 8.39 (10.409) 7.97 (15.304) 5.00 (6) 5.00 (5) MWU = 5464.0 0.894 
  80-89yrs 10.40 (11.502) 8.66 (9.678) 6.00 (8) 6.00 (5) MWU = 5349.0 0.459 
  90-99yrs 10.65 (11.615) 8.90 (10.452) 6.50 (10) 4.50 (10) MWU = 291.5 0.383 
Admission Type       
  Acute 10.58 (11.715) 9.20 (14.876) 6.00 (8) 6.00 (6) MWU = 17115.0 0.358 
  Elective 6.85 (7.989) 6.29 (9.34) 6.50 (10) 4.00 (5) MWU = 1957.0 0.953 
Hospital       
  Rural public 6.83 (5.348) 9.36 (11.050) 5.00 (3) 5.00 (9) MWU =1085.5 0.925 
  Urban public 11.04 (12.752) 8.91 (15.728) 6.00 (9) 5.00 (6) MWU = 13532.0 0.264 
  Urban private 8.88 (5.384) 5.81 (4.662) 7.50 (7) 5.00(6) MWU = 246.5 0.054 
Speciality of admitting team      
  Surgical 8.79 (13.435) 7.44 (10.496) 4.00 (6) 5.00 (5) MWU = 665.5 0.331 
  Medical 9.04 (10.087) 7.32 (7.260) 5.00 (8) 5.00 (6) MWU = 14093.5 0.393 
  Geriatric & orthopaedic 13.26 (13.251) 16.81 (34.458) 7.00 (12) 7.00 (10) MWU = 572.5 0.379 
Home type       
  Home alone 11.13 (12.336) 9.76 (11.775) 6.00 (11) 6.00 (7) MWU = 2000.0 0.494 
  Home & others 11.61 (12.317) 7.55 (14.349) 7.00 (11) 5.00 (5) MWU = 9300.0 0.002 
  Sheltered 5.29 (2.563) 7.91 (9.115) 6.00 (3) 4.00 (8) MWU = 35.0 0.749 
  Nursing home 4.41 (2.291) 7.25 (5.230) 4.00 (2) 7.50 (10) MWU = 81.0 0.284 
Destination at discharge       
  Home  7.53 (7.903) 6.49 (6.386) 5.00 (6) 5.00 (5) MWU = 13913.0 0.414 
  Nursing Home (LTC)§ 14.00 (17.371) 31.56 (52.807) 5.00 (17) 13.50 (34) MWU = 221.0 0.230 
  Non-home (STC)¶ 12.24 (8.227) 13.23 (14.793) 11.00 (14) 9.00 (9) MWU = 420.5 0.559 
  Deceased 9.46 (8.171) 14.75 (15.276) 7.00 (11) 10.00 (11) MWU = 36.0 0.244 
First Diagnosis       
  Cardiac  10.35 (8.616) 6.94 (7.620) 6.00 (16) 4.00 (5) MWU = 675.0 0.083 
  Respiratory 6.67 (4.676) 11.11 (10.921) 6.00 (7) 8.00 (9) MWU = 83.5 0.344 
  Pneumonia 12.22 (14.001) 8.16 (6.140) 6.00 (12) 7.00 (4) MWU = 512.5 0.995 
  Urinary tract infection 18.75 (19.374) 7.67 (11.169) 11.50 (35) 3.00 (5) MWU = 16.5 0.059 
  Gastrointestinal 9.64 (7.201) 7.73 (6.980) 7.00 (13) 6.00 (7) MWU = 20.35 0.416 
  Infections 7.33 (3.724) 10.00 (10.392) 7.50 (7) 6.50 (13) MWU = 23.0 0.950 
  Stroke 6.00 (4.000) 16.39 (45.383) 5.00 (7) 5.00 (6) MWU = 65.0 0.828 
  Cancer 12.00 (9.764) 9.57 (6.366) 9.50 (18) 9.00 (10) MWU = 37.5 0.576 
  Other 10.40 (12.226) 8.80 (10.242) 5.00 (7) 5.00 (7) MWU = 1598.5 0.448 
  Surgery/procedure 2.40 (1.765) 5.87 (9.011) 2.00 (3) 4.00 (4) MWU = 359.5 0.001 
†SD – standard deviation; ‡IQR – interquartile range; §LTC – long-term care; ¶STC – short-term care; 
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Table 2  Total cost statistics of patients with and without dementia 
Factor Dementia              
Mean (SD)† 
No Dementia                
Mean (SD)† 
Dementia    
Median (IQR)‡ 
No Dementia 
Median (IQR)‡ 
Test P-value 
Overall €8,246 (€9,336) €6,855 (€11,045) €4,560 (€7,128) €4,145 (€4,974) MWU = 30103.5 0.108 
Gender       
  Male €7,780 (€9,911) €6,304 (€7,365) €4,145 (€5,181) €4,145 (€4,974) MWU = 6951.5 0.842 
  Female €8,582 (€8,943) €7,432 (€13,884) €5,473 (€8,497) €4,145 (€5,181) MWU = 8135.5 0.072 
Age Group       
  70-79yrs €7,021 (€8,731) €6,632 (€12,633) €4,145 (€4,996) €4,145 (€4,145) MWU = 5511.0 0.964 
  80-89yrs €8,631 (€9,514) €7,176 (€7,991) €5,135 (€6,660) €4,974 (€4,145) MWU = 5340.5 0.448 
  90-99yrs €8,897 (€9,785) €7,370 (€8,664) €5,811 (€7,876) €3,731 (€7,876) MWU = 296.0 0.429 
Admission Type       
  Acute €8,819 (€9,770) €7,637 (€12,203) €4,974 (€6,688) €4,974 (€5,030) MWU = 17069.5 0.338 
  Elective €5,679 (€6,624) €5,248 (€7,967) €4,145 (€4,974) €3,316 (€4,145) MWU = 1963.0 0.973 
Hospital       
  Rural public €5,688 (€4,432) €7,785 (€9,177) €4,145 (€2,487) €4,145 (€7,461) MWU = 1081.0 0.898 
  Urban public €9,200 (€10,635) €7,400 (€12,972) €5,013 (€7,715) €4,145 (€4,974) MWU = 13547.5 0.271 
  Urban private €7,357 (€4,463) €4,836 (€3,883) €6,218 (€5,596) €4,145 (€4,767) MWU = 248.0 0.056 
Speciality of admitting team      
  Surgical €7,432 (€11,391) €6,209 (€8,954) €3,316 (€4,767) €4,145 (€4,145) MWU = 662.5 0.320 
  Medical €7,502 (€8,352) €6,095 (€6,071) €4,145 (€6,632) €4,145 (€4,974) MWU = 14077.5 0.385 
  Geriatric & orthopaedic €11,088 (€11,097) €13,832 (€28,108) €5,803 (€10,724) €5,754 (€8,533) MWU = 566.0 0.342 
Home type       
  Home alone €9,232 (€10,257) €8,142 (€9,978) €4,974 (€9,119) €4,974 (€6,057) MWU = 2007.0 0.513 
  Home & others €9,687 (€10,278) €6,261 (€11,738) €5,803 (€9,119) €4,145 (€4,145) MWU = 9273.0 0.002 
  Sheltered €4,382 (€2,125) €6,570 (€7,566) €4,974 (€2,487) €3,316 (€6,632) MWU = 35.0 0.791 
  Nursing home €3,686 (€1,962) €6,053 (€4,345) €3,316 (€1,658) €6,387 (€8,083) MWU = 79.0 0.269 
Destination at discharge       
  Home  €6,248 (€6,518) €5,397 (€5,350) €4,145 (€4,974) €4,145 (€4,145) MWU = 13941.5 0.430 
  Nursing Home (LTC)§ €11,664 (€14,497) €25,908 (€43,010) €4,145 (€14,093) €11,192 (€27,979) MWU = 217.50 0.204 
  Non-home (STC)¶ €10,195 (€6,813) €11,068 (€12,691) €9,119 (€11,440) €7,461 (€7,142) MWU = 418.5 0.541 
  Deceased €8,039 (€7,196) €12,228 (€12,664) €5,803 (€9,176) €8,290 (€8,912) MWU = 37.0 0.301 
First Diagnosis       
  Cardiac  €8,682 (€7,350) €5,811 (€6,422) €5,457 (€13,264) €3,316 (€4,089) MWU = 672.5 0.080 
  Respiratory €5,522 (€3,882) €9,204 (€9,056) €4,974 (€5,810) €6,632 (€7,047) MWU = 83.5 0.344 
  Pneumonia €10,150 (€11,615) €6,735 (€5,088) €5,135 (€9,724) €5,803 (€2,919) MWU = 505.0 0.915 
  Urinary tract infection €15,521 (€15,983) €6,334 (€9,261) €9,534 (€28,336) €2,487 (€3,633) MWU = 15.5 0.046 
  Gastrointestinal €8,059 (€6,053) €6,416 (€5,800) €5,803 (€11,553) €4,974 (€5,389) MWU = 203.0 0.410 
  Infections €6,070 (€3,097) €8,289 (€8,617) €6,218 (€6,053) €5,389 (€10,363) MWU = 23.5 0.950 
  Stroke €5,030 (€3,419) €13,420 (€36,975) €4,145 (€5,888) €4,145 (€4,862) MWU = 62.5 0.733 
  Cancer €9,948 (€8,094) €7,966 (€5,331) €7,876 (€14,922) €7,461 (€8,290) MWU = 38.0 0.622 
  Other €8,679 (€10,225) €7,319 (€8,535) €4,145 (€6,024) €4,145 (€5,803) MWU = 1615.0 0.502 
  Surgery/procedure €1,988 (€1,465) €4,905 (€7,792) €1,658 (€2,487) €3,316 (€3,316) MWU = 355.0 0.001 
†SD – standard deviation; ‡IQR – interquartile range; §LTC – long-term care; ¶STC – short-term care; 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
